134 related articles for article (PubMed ID: 15147729)
1. An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breast cancer cell lines.
Panjehpour M; Karami-Tehrani F
Int J Biochem Cell Biol; 2004 Aug; 36(8):1502-9. PubMed ID: 15147729
[TBL] [Abstract][Full Text] [Related]
2. An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation.
Lu J; Pierron A; Ravid K
Cancer Res; 2003 Oct; 63(19):6413-23. PubMed ID: 14559831
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells.
Kim SJ; Min HY; Chung HJ; Park EJ; Hong JY; Kang YJ; Shin DH; Jeong LS; Lee SK
Cancer Lett; 2008 Jun; 264(2):309-15. PubMed ID: 18321638
[TBL] [Abstract][Full Text] [Related]
4. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line.
Amlal H; Faroqui S; Balasubramaniam A; Sheriff S
Cancer Res; 2006 Apr; 66(7):3706-14. PubMed ID: 16585197
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism.
Mlejnek P; Dolezel P
Acta Physiol (Oxf); 2010 Jun; 199(2):171-9. PubMed ID: 20121715
[TBL] [Abstract][Full Text] [Related]
6. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A
J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of ANP secretion by 2-Cl-IB-MECA through A(3) receptor and CaMKII.
Yuan K; Bai GY; Park WH; Kim SZ; Kim SH
Peptides; 2008 Dec; 29(12):2216-24. PubMed ID: 18838091
[TBL] [Abstract][Full Text] [Related]
8. Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype.
Gessi S; Merighi S; Varani K; Cattabriga E; Benini A; Mirandola P; Leung E; Mac Lennan S; Feo C; Baraldi S; Borea PA
J Cell Physiol; 2007 Jun; 211(3):826-36. PubMed ID: 17348028
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
Mlejnek P; Dolezel P; Kosztyu P
J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
11. Homeostatic action of adenosine A3 and A1 receptor agonists on proliferation of hematopoietic precursor cells.
Hofer M; Pospísil M; Znojil V; Holá J; Streitová D; Vacek A
Exp Biol Med (Maywood); 2008 Jul; 233(7):897-900. PubMed ID: 18445770
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial and caspase pathways are involved in the induction of apoptosis by IB-MECA in ovarian cancer cell lines.
Abedi H; Aghaei M; Panjehpour M; Hajiahmadi S
Tumour Biol; 2014 Nov; 35(11):11027-39. PubMed ID: 25095978
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of adenosine receptors on growth of human colon cancer HCT 116 and HT-29 cell lines.
Sakowicz-Burkiewicz M; Kitowska A; Grden M; Maciejewska I; Szutowicz A; Pawelczyk T
Arch Biochem Biophys; 2013 May; 533(1-2):47-54. PubMed ID: 23454010
[TBL] [Abstract][Full Text] [Related]
14. Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.
Fishman P; Bar-Yehuda S; Ardon E; Rath-Wolfson L; Barrer F; Ochaion A; Madi L
Anticancer Res; 2003; 23(3A):2077-83. PubMed ID: 12894581
[TBL] [Abstract][Full Text] [Related]
15. The A3 adenosine receptor as a new target for cancer therapy and chemoprotection.
Fishman P; Bar-Yehuda S; Barer F; Madi L; Multani AS; Pathak S
Exp Cell Res; 2001 Oct; 269(2):230-6. PubMed ID: 11570815
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis in cardiac myocytes by an A3 adenosine receptor agonist.
Shneyvays V; Nawrath H; Jacobson KA; Shainberg A
Exp Cell Res; 1998 Sep; 243(2):383-97. PubMed ID: 9743598
[TBL] [Abstract][Full Text] [Related]
17. An A3-subtype adenosine receptor is highly expressed in rat vascular smooth muscle cells: its role in attenuating adenosine-induced increase in cAMP.
Zhao Z; Francis CE; Ravid K
Microvasc Res; 1997 Nov; 54(3):243-52. PubMed ID: 9441895
[TBL] [Abstract][Full Text] [Related]
18. Novel N2-substituted pyrazolo[3,4-d]pyrimidine adenosine A3 receptor antagonists: inhibition of A3-mediated human glioblastoma cell proliferation.
Taliani S; La Motta C; Mugnaini L; Simorini F; Salerno S; Marini AM; Da Settimo F; Cosconati S; Cosimelli B; Greco G; Limongelli V; Marinelli L; Novellino E; Ciampi O; Daniele S; Trincavelli ML; Martini C
J Med Chem; 2010 May; 53(10):3954-63. PubMed ID: 20408530
[TBL] [Abstract][Full Text] [Related]
19. Effects of adenosine A(3) receptor agonist on bone marrow granulocytic system in 5-fluorouracil-treated mice.
Hofer M; Pospísil M; Vacek A; Holá J; Znojil V; Weiterová L; Streitová D
Eur J Pharmacol; 2006 May; 538(1-3):163-7. PubMed ID: 16643889
[TBL] [Abstract][Full Text] [Related]
20. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]